Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease

Archives of Neurology

Volumn 60, Issue 5, 2003, Pages 737-741

  Wu, Zhi Ying ^a   Lin, Min Ting ^a   Murong, Shen Xing ^a   Wang, Ning ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; ZINC SULFATE;

ADOLESCENT; ADULT; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CHINESE; COPPER METABOLISM; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; FEMALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; SCHOOL CHILD; SIDE EFFECT; TANDEM REPEAT; WILSON DISEASE;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CERULOPLASMIN; CHILD; COPPER; FEMALE; FOLLOW-UP STUDIES; HAPLOTYPES; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; ZINC SULFATE;

EID: 0038326583     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.5.737     Document Type: Article

References (16)

1. Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGrawHill Co; 1995:2211-2235.
2. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore). 1992; 71:139-164.
3. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med. 1968;278:352-359.
4. Brewer GJ, Turkay A, Yuzbaziyan-Gurkan V. Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine. Arch Neurol 1994;51:304-305.
5. Hoogenraad TU, Koevoet R, de Ruyter Korver EGWM. Oral zinc sulphate as longterm treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol. 1979;18:205-211.
6. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med. 1983;99:314-319.
7. Wu Z-Y, Wang N, Lin M-T, Fang L, Murong S-X, Yu L. Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in Chinese patients with Wilson disease. Arch Neurol. 2001;58:971-976.
8. Wu Z-Y, Yu L, Wang N. Gene diagnosis for hepatolenticular degeneration by genetic linkage analysis with four short tandem repeat polymorphisms [in Chinese]. Zhonghua Yi Xue Za Zhi. 1996;76:578-581.
9. Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113:212-218.
10. Faa G, Nurchi V, Demelia L, et al. Uneven hepatic copper distribution in Wilson's disease. J Hepatol. 1995;22:303-308.
11. Bull O PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5:327-337.
12. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5: 344-350.
13. Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Am J Hum Genet. 1995;57: 1318-1324.
14. Thomas GR, Bull PC, Roberts EA, Walshe JM, Cox DW. Haplotype studies in Wilson disease. Am J Hum Genet. 1994;54:71-78.
15. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998; 132:264-278.
16. Hoogenraad TU. Zinc treatment of Wilson's disease. J Lab Clin Med. 1998;132: 240-241.